Literature DB >> 6135365

Identification and intervention of heavy drinking in middle-aged men: results and follow-up of 24-60 months of long-term study with randomized controls.

H Kristenson, H Ohlin, M B Hultén-Nosslin, E Trell, B Hood.   

Abstract

In a continuing screening and intervention programme in Malmó, elevated serum-gamma-glutamyltransferase (GGT) values were used for selection of heavy drinkers. The study population consisted of 585 individuals born 1926-1933 with two consecutive GGT values in the upper decile of the GGT distribution, randomly allocated either to an intervention group of to a control group. The subjects in the intervention group were further investigated and 75% of them were judged to have elevated GGT values caused by alcohol consumption. These individuals were repeatedly encouraged to lower their overall alcohol consumption and GGT measurements were used as biofeedback method in the treatment program. The controls were informed by letter to be restrictive with their alcohol consumption and that they should receive new invitations for measurements of their liver enzymes after 2, 4, and 6 years. The intervention and control groups were well matched and followed over a 2-6-year period. Two and 4 years after the screening investigation, the GGT values in both groups were significantly decreased. There were differences, however, between the two groups with regard to sick absenteeism, hospitalization, and mortality. A significant reduction was found in sick absence during 4 years by 80%, in hospital days during 5 years by 60%, and in mortality during 6 years by 50% in the intervention group compared with the control group. Thus, the intervention program was effective in preventing medico-social consequences of heavy drinking.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135365     DOI: 10.1111/j.1530-0277.1983.tb05441.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  59 in total

1.  Predictors of patient entry into alcohol treatment after initial diagnosis.

Authors:  J E Kirchner; B M Booth; R R Owen; A E Lancaster; G R Smith
Journal:  J Behav Health Serv Res       Date:  2000-08       Impact factor: 1.505

Review 2.  Early identification of alcohol problems.

Authors:  J B Saunders; K M Conigrave
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

Review 3.  Brief interventions and alcohol use.

Authors:  N Freemantle; P Gill; C Godfrey; A Long; C Richards; T A Sheldon; F Song; J Webb
Journal:  Qual Health Care       Date:  1993-12

Review 4.  The diagnosis of drug dependence by primary care providers.

Authors:  D Shine
Journal:  J Gen Intern Med       Date:  1991 Jan-Feb       Impact factor: 5.128

5.  Harm reduction and individually focused alcohol prevention.

Authors:  Clayton Neighbors; Mary E Larimer; Ty W Lostutter; Briana A Woods
Journal:  Int J Drug Policy       Date:  2006-07

6.  The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.

Authors:  Aron N Starosta; Robert F Leeman; Joseph R Volpicelli
Journal:  J Psychiatr Pract       Date:  2006-03       Impact factor: 1.325

7.  Increased focus on the teaching of interactional skills to medical practitioners.

Authors:  J J Perkins; R W Sanson-Fisher
Journal:  Adv Health Sci Educ Theory Pract       Date:  1996-01       Impact factor: 3.853

8.  Physical health and drinking among medical inpatients with unhealthy alcohol use: a prospective study.

Authors:  Emily C Williams; Tibor Palfai; Debbie M Cheng; Jeffrey H Samet; Katharine A Bradley; Thomas D Koepsell; Thomas M Wickizer; Patrick J Heagerty; Richard Saitz
Journal:  Alcohol Clin Exp Res       Date:  2010-05-04       Impact factor: 3.455

9.  Brief interventions in substance abuse.

Authors:  S Kumar; A Malhotra
Journal:  Indian J Psychiatry       Date:  2000-04       Impact factor: 1.759

10.  Alcohol counseling: physicians will do it.

Authors:  A Adams; J K Ockene; E V Wheller; T G Hurley
Journal:  J Gen Intern Med       Date:  1998-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.